SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 126.31-0.2%12:16 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonki who wrote (17)5/29/1997 4:50:00 PM
From: Eric Dickson   of 296
 
This company is just about a year old product of a merger of two big drug companys. I've been following it for a couple of months and its been a steady preformer. Here's a snapshot from the motley fool website:

Novartis AG
OTC: NVTSY
novartis.com
Lichtstrasse 35
CH-4002 Basel, Switzerland
Ph: 011-41-61-324-111
Fx: 011-41-61-324-330
Novartis, the product of the 1996 merger of Ciba-Geigy and Sandoz, is the world's #1 maker of generic drugs and pharmaceuticals (edging out perennial leader Glaxo Wellcome). Its pharmaceutical division also includes over-the-counter products and contact lenses, lens care products, and ophthalmic medications. The company's agribusiness division is the world's #1 producer of herbicides, insecticides, and fungicides for crop protection; it also produces parasite-control products and medicines for pets and farm animals, and seeds for hardier, higher-yield crops. Novartis is one of the world's largest providers of medical nutrition products, and it also makes baby food (Gerber, #1 in US) and health and dietetic products.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext